Effect of lysine antifibrinolytics and COX inhibitors on the proteolytic profile of breast cancer cells interacting with macrophages or endothelial cells. Afsharimani B., P.J. Cabot, M.O. Parat. Br. J. of Anaesth., 2014 113 (S1): i22–i31 (IF 6.238). https://www.ncbi.nlm.nih.gov/pubmed/24418973

Morphine and breast tumour metastasis: the role of matrix-degrading enzymes. Afsharimani B., J. Baran, S. Watanabe, D. Lindner, P.J. Cabot, M.O. Parat. Clinical and Experimental Metastasis 31(2):149-158, 2014 (IF 3.144). https://www.ncbi.nlm.nih.gov/pubmed/24072419